HOME >> MEDICINE >> NEWS
AAPS workshop to explore pharmaceutical reference standards

The American Association of Pharmaceutical Scientists (AAPS) will present the AAPS Workshop on Reference Standards: Science, Methodologies and Compliance of Current and Emerging Pharmaceutical Products, May 15-16, 2000 at the Crystal Gateway Marriott in Arlington, Va.

"This is the first workshop in several years dedicated exclusively to pharmaceutical reference standards," said Moheb M. Nasr, Ph.D., Food and Drug Administration. "This workshop will not only educate new scientists but will also provide more experienced scientists and managers a forum for discussion."

The objective of the workshop is to provide an update on current and emerging issues in the development, characterization and use of reference standards. The workshop will be of particular interest to pharmaceutical scientists working in analytical research and development, quality assurance and control, regulatory affairs and compliance and related disciplines.

Workshop topics include:

  • Evolution of reference standards throughout drug discovery, development and post-marketing
  • Characterization of Reference Standard Materials using a variety of analytical techniques
  • Compendial review of and approval process (U.S. Pharmacopeia and International Pharmacopeias)
  • Practical considerations for a successful reference standard program: maintenance, storage, use and requalification
  • Reference standards used in the analysis of biotechnological and botanical drug products.
  • Use of reference standards in comparitor studies for New Chemical Entities Reference standards used in the calibration and qualification of laboratory instruments
  • Analytical approaches when reference standards are not available


'"/>

Contact: Debbie Mierke
mierke@aaps.org
703-248-4743
American Association of Pharmaceutical Scientists
30-Apr-2000


Page: 1

Related medicine news :

1. NIH convenes workshop on menopausal hormone therapy
2. Hands-on cancer biology workshop for journalists
3. AAPS kicks off new century with workshop on bioanalytical methods validation
4. PQRI workshop to address blend uniformity
5. AAPS workshop to explore regulatory approaches to bioavailability, bioequivalence
6. AAPS workshop to examine changes in analytical methods and packaging
7. AAPS presents workshop on macromolecules
8. NPSF workshop builds community to improve pharmaceutical safety
9. Researcher explores ways to make hypnosis a more effective therapeutic technique
10. Impact of scientific advances on drug studies and membrane research to be explored
11. Study explores risks of obesity in children with kidney transplants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... Based on worldwide ... and efficacy of HBOT in treating and helping to heal addictions and substance ... showing the similarities of the wounds to the brain from traumatic brain injuries, ...
(Date:8/23/2017)... ... August 23, 2017 , ... PreCheck, Inc., ... 2017 Inc. 5000 with a three-year sales growth of 49 percent . ... and comprises the most comprehensive look at America’s independent entrepreneurs. This represents PreCheck’s ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... today that has been named to the 2017 Inc. 500|5000, an exclusive ranking ... a three-year growth rate of 139 percent, marking the twelfth year that the ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... American Academy of Orthopaedic Surgeons , points out that therapeutic modalities (physical ... pain or injury. According to the report, a wider scope of physical therapy ...
(Date:8/22/2017)... California (PRWEB) , ... August 22, 2017 , ... ... that the key to good health is as simple as eating healthy foods. ... food—whether it be storing fat, making insulin, or breaking apart carbohydrates—depends not only ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Mich. , Aug. 15, 2017 Diplomat ... naloxone to Michigan residents. ... Flint retail pharmacy, G-3320 Beecher ... approved by the Food and Drug Administration, is intended ... extreme drowsiness, slowed breathing, and loss of consciousness. The ...
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... DUBLIN, Aug. 8, 2017   ... $3.12 diluted (GAAP) loss per share from continuing operations ... Products revenues increased 16 percent to $110 million ... increased 27 percent to $161 million ... (EPS) from continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology:
Cached News: